Geneos Wealth Management’s Greenwich LifeSciences GLSI Stock Holding History

Geneos Wealth Management’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.59K	Hold	88	–	–	﹤0.01%	2978
2026 Q2	$2.06K	Hold	88	–	–	﹤0.01%	2319
2026 Q1	$2.11K	Hold	88	–	–	﹤0.01%	2311
2025 Q4	$1.85K	Hold	88	–	–	﹤0.01%	2327
2025 Q3	$876	Hold	88	–	–	﹤0.01%	2417
2025 Q2	$798	Hold	88	–	–	﹤0.01%	3042
2025 Q1	$840	Hold	88	–	–	﹤0.01%	2972
2024 Q4	$988	Hold	88	–	–	﹤0.01%	2771
2024 Q3	$1.26K	Hold	88	–	–	﹤0.01%	2393
2024 Q2	$1.52K	Hold	88	–	–	﹤0.01%	1929
2024 Q1	$1.76K	Hold	88	–	–	﹤0.01%	1921
2023 Q4	$926	Hold	88	–	–	﹤0.01%	2023
2023 Q3	$778	Hold	88	–	–	﹤0.01%	2057
2023 Q2	$849	Buy	+88	New	+$984	﹤0.01%	2034

Other funds holding GLSI

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return

Geneos Wealth Management's GLSI Position: Q3 2026 in Review

Geneos Wealth Management held its Greenwich LifeSciences (GLSI) position steady in Q3 2026 at 88 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2978.

Geneos Wealth Management first reported a position in GLSI in Q2 2023 and has held it in 14 quarters since. The position peaked at $2.11K in Q1 2026. 25 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

Geneos Wealth Management held 88 shares of Greenwich LifeSciences worth $1.59K as of Q3 2026.
Geneos Wealth Management left its Greenwich LifeSciences share count unchanged in Q3 2026.
Greenwich LifeSciences made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2978 holding.
Geneos Wealth Management first reported a position in Greenwich LifeSciences in Q2 2023 and has held it in 14 quarters since.
Geneos Wealth Management's Greenwich LifeSciences position peaked at $2.11K in Q1 2026.
25 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.